HYBRIGENICS (EPA:ALHYG) | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129233	Press releases

Home
Companies
HYBRIGENICS

BRIEF

published on 08/24/2026 at 18:05, 18 days 19 hours ago

Aton completes the repayment of its ORAs subscribed with Iris Capital

Strategic Development Funding Aton IRIS Capital ORA Reimbursement
BRIEF

published on 08/24/2026 at 18:05, 18 days 19 hours ago

Aton achève le remboursement de ses ORA souscrites auprès d'Iris Capital

Financement Développement Stratégique Aton IRIS Capital Remboursement ORA
PRESS RELEASE

published on 08/24/2026 at 18:00, 18 days 19 hours ago

ATON ANNONCE LE REMBOURSEMENT INTEGRAL DES ORA SOUSCRITES AUPRES D'IRIS CAPITAL
Le Groupe Aton annonce le remboursement intégral des obligations remboursables en actions (ORA) émises dans le cadre de sa ligne de financement, marquant une nouvelle étape dans l'assainissement de son bilan

Financement Groupe Aton Remboursement Assainissement Obligations Remboursables En Actions
BRIEF

published on 06/25/2026 at 18:20, 2 months 16 days ago

Pims Technology: Towards Optimizing Cancer Treatments

Oncology Personalized Medicine PIMS Technology European Presence Therapeutic Evaluation
BRIEF

published on 06/25/2026 at 18:20, 2 months 16 days ago

Pims Technology : Vers une Optimisation des Traitements Oncologiques

Oncologie Médecine Personnalisée Technologie PIMS Évaluation Thérapeutique Implantation Européenne
PRESS RELEASE

published on 06/25/2026 at 18:15, 2 months 16 days ago

PIMS TECHNOLOGY : UNE TECHNOLOGIE QUI VISE A EVITER DES MILLIARDS D'EUROS DE TRAITEMENTS INEFFICACES EN ONCOLOGIE
Publication du Groupe Aton sur sa filiale Pims Technology et sa technologie d'évaluation de la réponse des patients aux traitements grâce à leur empreinte moléculaire

Oncologie Médecine Personnalisée Groupe Aton PIMS Technology Empreinte Moléculaire
BRIEF

published on 05/07/2026 at 10:05, 4 months 5 days ago

Aton Group is organizing a webinar for shareholders and investors on May 12, 2026

Shareholders Biotechnology Webinar 2025 Results Aton Group
BRIEF

published on 05/07/2026 at 10:05, 4 months 5 days ago

Groupe Aton organise un webinaire pour actionnaires et investisseurs le 12 mai 2026

Actionnaires Biotechnologie Webinaire Groupe Aton Résultats 2025
PRESS RELEASE

published on 05/07/2026 at 10:00, 4 months 5 days ago

WEBINAIRE ATON DESTINÉ AUX ACTIONNAIRES ET INVESTISSEURS INDIVIDUELS MARDI 12 MAI 2026 À 18H00
Le Groupe Aton, spécialisé en sciences médicales, organise une visioconférence pour présenter les résultats 2025 et perspectives. Actionnaires et investisseurs individuels invités. Inscription en ligne

Visioconférence Investisseurs Groupe Aton Sciences Médicales Résultats 2025
BRIEF

published on 04/28/2026 at 18:05, 4 months 13 days ago

Résultats annuels 2025 : Groupe Aton

Partenariats Stratégiques Expansion Commerciale Groupe Aton Biotechnologies Résultats 2025

1 2 ... 7

Accesswire

Published on 09/12/2026 at 02:35, 10 hours 48 minutes ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 23 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 18 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 15 hours 58 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 23 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 5 hours 53 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 8 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 13 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 17 hours 39 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 8 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 6 hours ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 17 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE